Literature DB >> 19351578

DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: a comparison study.

Rael D Strous1, Rachel Maayan, Masha Kaminsky, Rachel Blumensohn, Abraham Weizman, Baruch Spivak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19351578     DOI： 10.1016/j.euroneuro.2009.03.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


× No keyword cloud information.
  4 in total

Review 1.  The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

Authors:  Guillaume Fond; Marc-Antoine d'Albis; Stéphane Jamain; Ryad Tamouza; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Markus Leweke; Shôn Lewis; Phillip McGuire; Andreas Meyer-Lindenberg; Iris E Sommer; Inge Winter-van Rossum; Shitij Kapur; René S Kahn; Dan Rujescu; Marion Leboyer
Journal:  Schizophr Bull       Date:  2015-03-10       Impact factor: 9.306

Review 2.  Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

Authors:  Y S L Powrie; C Smith
Journal:  J Neuroinflammation       Date:  2018-10-16       Impact factor: 8.322

3.  Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia.

Authors:  Murat Beyazyüz; Yakup Albayrak; Elmas Beyazyüz; Cüneyt Unsal; Erol Göka
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-29       Impact factor: 2.570

4.  Understanding the Demographic Predictors and Associated Comorbidities in Children Hospitalized with Conduct Disorder.

Authors:  Rikinkumar S Patel; Neelima Amaravadi; Harkeerat Bhullar; Jay Lekireddy; Honey Win
Journal:  Behav Sci (Basel)       Date:  2018-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.